Introduction: Recent researches pointed out the role of new derivative indices (C reactive protein to albumin ratio-CAR, neutrophil to lymphocyte ratio-NLR, platelet to lymphocyte ratio-PLR) as biomarkers of disease activity in patients with rheumatic diseases, including rheumatoid arthritis (RA) [1-5]. This evidence concerns the gene CRP and rheumatoid arthritis.